Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (271)

2024

  1. Inhibition of Adult Neurogenesis in Male Mice after Repeated Exposure to Paracetamol Overdose

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  2. Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study

    Toxics, Vol. 12, Núm. 3

  3. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments

    Biology of Sex Differences, Vol. 15, Núm. 1

2023

  1. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Acute intrahippocampal administration of melanin-concentrating hormone impairs memory consolidation and decreases the expression of MCHR-1 and TrkB receptors

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 123

  3. Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity

    Nutrients, Vol. 15, Núm. 20

  4. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  5. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  6. Dissecting operant alcohol self-administration using saccharin-fading procedure

    Neuropsychopharmacology Reports, Vol. 43, Núm. 1, pp. 12-22

  7. Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum

    Behavioral and Brain Functions, Vol. 19, Núm. 1

  8. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  9. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  10. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

  11. Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

  12. Social avoidance and altered hypothalamic-pituitary-adrenal axis in a mouse model of anxious depression: The role of LPA1 receptor

    Behavioural Brain Research, Vol. 455

  13. The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer’s Disease-like Pathogenesis

    International Journal of Molecular Sciences, Vol. 24, Núm. 23

  14. The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice

    Biology, Vol. 12, Núm. 6

  15. The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse

    Biomedicines, Vol. 11, Núm. 2

  16. Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice

    Brain Communications, Vol. 5, Núm. 1

2022

  1. Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113